Inventiva SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Inventiva SA with three other
miscellaneous service companies in Europe:
Avacta Group Plc
of the United Kingdom
sales of £2.76 million [US$3.56 million]
of which 57%
was Animal Health),
Alligator Bioscience Ab
(26.96 million Swedish Kronor [US$2.91 million]
Fusion Antibodies PLC
based in the United Kingdom
(£2.69 million [US$3.47 million]
Inventiva SA reported sales of 3.20 million Euro (US$3.62 million)
December of 2018.
decrease of 50.9%
versus 2017, when the company's sales were 6.52 million Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Inventiva SA had sales
of 3.07 million Euro.